We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Omega Diagnostics Group Plc | LSE:ODX | London | Ordinary Share | GB00B1VCP282 | ORD 4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 2.20 | 2.00 | 2.40 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
31/3/2019 13:35 | I am Norti Raskal and I am King of the Castle. My powers say Euro-Specs International are distributors in Nigeria. | raskal | |
31/3/2019 11:50 | My liege norti rascal.In your opinion . Volume wise what can omega expect with cd4 350 sales in Nigeria over the next six months. | upomega | |
31/3/2019 11:41 | the ayes have it the ayes have it | upomega | |
31/3/2019 10:12 | Orda orda. Point of order Norti Raskal. | likitorma | |
30/3/2019 01:07 | My name is Norti Raskal NOT naughty rascal and I'm also the King of the castle and not you. So you stand corrected. As for the Nigerian company I wouldn't get over excited about volumes rather the initial placement of Visitect into the distribution channels. It's the NGO's that will make up the volumes and thereby the numbers. | raskal | |
29/3/2019 16:41 | He/she didn't even spell the rascal properly. Waste of time. | likitorma | |
29/3/2019 14:41 | Thanks Barry. I did wonder. The nickname says it all really | upomega | |
29/3/2019 14:30 | Don’t take any notice of the post upomega, it’s his first post and just another alias... | barrywhit | |
29/3/2019 13:13 | You have to bow down to the request of our well researched and soon to be 2% major shareholder. | likitorma | |
29/3/2019 10:49 | Raskal Have you the name of the company. Alternatively a link to their website if they have one | upomega | |
29/3/2019 02:01 | Has anybody checked out this Nigerian company? I had a look at it and it's small beer. They distribute a few tests one of the directors the finance I think sells clothes. It nearer a moma and papa business-but it's a starting point in a potentially large market. Cheers Norti Raskal | raskal | |
27/3/2019 19:04 | ive opened it Barry. I tried to cut/paste before logging in, but managed it by logging into advfn | upomega | |
27/3/2019 18:55 | upomega, very strange, I have just opened using the link...it is a PDF you can find the link on ODX twitter link in the header..Their latest Tweet... | barrywhit | |
27/3/2019 18:34 | Barry Have you got a summary you can post, As the link keeps saying page does not exist. Going forward I think we need a half decent order from Nigeria for CD4 350 shortly as personally I can see a finance gap until things take off later in the year | upomega | |
27/3/2019 14:05 | Worth a read through, lots of info on CD4 | barrywhit | |
21/3/2019 21:34 | Soon to be 2 percent | upomega | |
19/3/2019 06:37 | I would have thought that our 1% holder, who has performed extensive research about the company, would be familiar with the board members. | likitorma | |
18/3/2019 22:58 | I may be missing something here. Who is grewal and how does this effect omega. Please enlightenment me and any new investors who may be effected in airports' and sunsets etc | upomega | |
18/3/2019 22:34 | Seems Grewal busy posting pics of sunrise at Heathrow on Twitter instead of addressing share price. | likitorma | |
18/3/2019 22:12 | Well lets just hope that a hostile predator isn't looming | upomega | |
18/3/2019 21:39 | Still pitiful share price hahaha | likitorma | |
18/3/2019 19:39 | Barry Inmo. Its not traders,but people selling stock into either an Isa or sip I,ll be doing the same myself in a few weeks | upomega | |
18/3/2019 19:32 | Maybe he or she was the interviewer.Alternat | upomega | |
18/3/2019 15:46 | Body language in a press article ffs. Where do they find them? | gwr7 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions